Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis

Hepatology

Volumn 56, Issue 1, 2012, Pages 228-238

  Merchante, Nicolás ^a   Rivero Juárez, Antonio ^b   Téllez, Francisco ^c   Merino, Dolores ^d   José Ríos Villegas, Maria ^e   Márquez Solero, Manuel ^f   Omar, Mohamed ^g   Macías, Juan ^a   Camacho, Ángela ^b   Pérez Pérez, Montserrat ^c   Gómez Mateos, Jesús ^a   Rivero, Antonio ^b   Antonio Pineda, Juan ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c Unidad de Enfermedades Infecciosas   (Spain)

^d HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^g Unidad de Enfermedades Infecciosas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VIRUS RNA;

ADULT; ARTICLE; COMPENSATED LIVER CIRRHOSIS; DISEASE COURSE; ELASTOGRAPHY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER STIFFNESS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; VIRUS LOAD;

ADAPTATION, PHYSIOLOGICAL; ADULT; AGE FACTORS; BIOPSY, NEEDLE; COHORT STUDIES; COINFECTION; CONFIDENCE INTERVALS; DISEASE PROGRESSION; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER FAILURE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL RATE;

EID: 84863509752     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25616     Document Type: Article

References (38)

1. Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010; 50: 1387-1396.
2. Weber R, Sabin C, Friis-Moller N, Reiss P, El-Sadr W, Kirk O, et al. Liver-related deaths in persons infected with the HIV: the D:A:D study. Arch Intern Med 2006; 166: 1632-1641.
3. Pineda JA, García-García JA, Aguilar-Guisado M, Rios-Villegas MJ, Ruiz-Morales J, Rivero A, et al. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. HEPATOLOGY 2007; 46: 622-630.
4. Pineda JA, Romero-Gómez M, Díaz-García F, Girón-González JA, Montero JL, Torre-Cisneros J, et al. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. HEPATOLOGY 2005; 41: 779-789.
5. Girón-González JA, Brun F, Terrón A, Vergara A, Arizcorreta A. Natural history of compensated and decompensated HCV-related cirrosis in HIV-infected patients: a prospective multicentre study. Antivir Ther 2007; 12: 899-907.
6. Merchante N, Girón-González JA, González-Serrano M, Torre-Cisneros J, García-García JA, Arizcorreta A, et al. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS 2006; 20: 49-57.
7. Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-350.
8. Ziol M, Handra-Luca A, Kettaneh A, Chirstidis C, Mal F, Kazemi F, et al. Non-invasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. HEPATOLOGY 2005; 41: 48-54.
9. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Lédinghen V, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009; 29: 242-247.
10. Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouillères O, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. HEPATOLOGY 2006; 43: 1118-1124.
11. Yoneda M, Fujita K, Inamori M, Nakajima, A, Tamamo M, Hiraishi H. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD). Gut 2007; 56: 1130-1131.
12. Ganne-Carrie N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. HEPATOLOGY 2006; 44: 1511-1517.
13. de Lédinghen V, Douvin C, Kettaneh A, Ziol M, Roulot D, Marcellin P, et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/Hepatitis C virus-coinfected patients. J Acquir Immune Defic Syndr 2006; 41: 175-179.
14. Vergara S, Macías J, Rivero A, Gutiérrez-Valencia A, González-Serrano M, Merino D, et al. The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. Clin Infect Dis 2007; 45: 969-974.
15. Macías J, Recio E, Vispo E, Rivero A, López-Cortés LF, Ríos MJ, et al. Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients. J Hepatol 2008; 49: 916-922.
16. Foucher J, Chanteloup E, Vergniol J, Castéra L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403-408.
17. Bureau C, Metivier S, Peron JM, Selves J, Robic MA, Gourraud PA, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther 2008; 27: 1261-1268.
18. Kazemi F, Kettaneh A, N'Kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large esophageal varices. J Hepatol 2006; 45: 230-235.
19. Castera L, Le B, Roudot-Thoraval F, Bernard P, Foucher J, Merrouche W, et al. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory test and noninvasive scores. J Hepatol 2009; 50: 59-68.
20. Pineda JA, Recio E, Camacho A, Macías J, Almodóvar C, González-Serrano M, et al. Liver stiffness as a predictor of esophageal varices requiring therapy in HIV/Hepatitis C virus-coinfected patients with cirrhosis. J Acquir Immune Defic Syndr 2009; 51: 445-449.
21. Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. HEPATOLOGY 2007; 45: 1290-1297.
22. Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006; 12: 1791-1798.
23. Sánchez-Conde M, Miralles P, Bellón JM, Rincón D, Ramírez M, Gutiérrez I, et al. Use of transient elastography (FibroScan®) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients. J Viral Hep 2011; 18: 685-691.
24. Tuma P, Jarrin I, Del Amo J, Vispo E, Medrano J, Martín-Carbonero L, et al. Survival of HIV-infected patients with compensated liver cirrhosis. AIDS 2010; 24: 745-753.
25. Merchante N, Jiménez-Sáez M, Pineda JA. Management of HCV-related end-stage liver disease in HIV-coinfected patients. AIDS Rev 2007; 9: 131-139.
26. Child C, Turcotte J. Surgery and portal hypertension. Major Probl Clin Surg 1964; 1: 1-85.
27. Kammath PS, Wiesner RH, Malinhchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001; 33: 464-470.
28. Idezuki Y. General rules for recording endoscopic findings of esophagogastric varices (1991). Japanese Society of Portal Hypertension. World J Surg 1995; 19: 420-422.
29. Soriano V, Puoti M, Sulkowski M, Cargnel A, Benhamou Y, Peters M, et al. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV international panel. AIDS 2007; 21: 1073-1089.
30. Wai CT, Greeson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple non invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. HEPATOLOGY 2003; 38: 518-526.
31. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple non invasive index to predict significant fibrosis in patients with HIV/HCV coinfection. HEPATOLOGY 2006; 43: 1317-1325.
32. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157-172.
33. Pineda JA, Aguilar-Guisado M, Rivero A, Girón-González JA, Ruiz-Morales J, Merino D, et al. Natural history of compensated liver hepatitis C virus-related cirrhosis in HIV-infected patients. Clin Infect Dis 2009; 49: 1274-1282.
34. Ragni M, Eghtesad B, Schlesinger K, Dvorchik I, Fung J. Pre-trasnplant survival is shorter in HIV-positive than HIV-negative with end-stage liver disease. Liver Transpl 2005; 11: 1425-1430.
35. Murillas J, Rimola A, Laguno M, de Lazzari E, Rascon J, Aguero F, et al. The model for end-stage liver disease score is the best prognostic factor in HIV-1-infected patients with end-stage liver disease: a prospective cohort study. Liver Transpl 2009; 15: 1133-1141.
36. Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med 2007; 147: 677-684.
37. Berenguer J, Alvarez-Pellicer J, Martín PM, López-Aldeguer J, Von-Wichmann MA, Quereda C, et al. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. HEPATOLOGY 2009; 50: 407-413.
38. López-Diéguez M, Montes M, Pascual-Pareja JF, Quereda C, Von Wichmann MA, Berenguer J, et al. The natural history of liver cirrhosis in HIV-HCV coinfected patients. AIDS 2011; 25: 899-904.